ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.57
+0.39 (2.57%)
At close: Feb 27, 2026, 4:00 PM EST
15.28
-0.29 (-1.86%)
After-hours: Feb 27, 2026, 7:45 PM EST
ADMA Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 | Upgrade
|
| Cash & Short-Term Investments | 87.63 | 103.15 | 51.35 | 86.52 | 51.09 | Upgrade
|
| Cash Growth | -15.04% | 100.86% | -40.65% | 69.36% | -8.64% | Upgrade
|
| Receivables | 158.43 | 50 | 27.42 | 15.51 | 28.58 | Upgrade
|
| Inventory | 206.47 | 170.24 | 172.91 | 163.28 | 124.72 | Upgrade
|
| Prepaid Expenses | 7.46 | 8.03 | 5.33 | 5.1 | 4.34 | Upgrade
|
| Other Current Assets | 6.53 | - | - | - | - | Upgrade
|
| Total Current Assets | 466.51 | 331.41 | 257.01 | 270.4 | 208.73 | Upgrade
|
| Property, Plant & Equipment | 71.71 | 63.34 | 63.47 | 68.75 | 58.2 | Upgrade
|
| Goodwill | 3.53 | 3.53 | 3.53 | 3.53 | 3.53 | Upgrade
|
| Other Intangible Assets | 0.63 | 0.46 | 0.5 | 1.01 | 1.73 | Upgrade
|
| Long-Term Deferred Tax Assets | 73.26 | 84.28 | - | - | - | Upgrade
|
| Other Long-Term Assets | 8.6 | 5.66 | 4.67 | 4.77 | 4.07 | Upgrade
|
| Total Assets | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 | Upgrade
|
| Accounts Payable | 22.52 | 20.22 | 15.66 | 13.23 | 12.43 | Upgrade
|
| Accrued Expenses | 27.68 | 28.63 | 30.55 | 23.19 | 16.23 | Upgrade
|
| Current Portion of Long-Term Debt | 2.81 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.1 | 1.22 | 1.05 | 0.91 | 0.59 | Upgrade
|
| Current Income Taxes Payable | 8.62 | 3.48 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.18 | 0.14 | 0.14 | Upgrade
|
| Other Current Liabilities | 6.82 | 2 | 2.37 | 1.8 | 0.98 | Upgrade
|
| Total Current Liabilities | 69.54 | 55.54 | 49.81 | 39.27 | 30.38 | Upgrade
|
| Long-Term Debt | 69.33 | 72.34 | 130.59 | 142.83 | 94.87 | Upgrade
|
| Long-Term Leases | 6.65 | 8.56 | 9.78 | 10.7 | 7.46 | Upgrade
|
| Long-Term Unearned Revenue | 1.41 | 1.55 | 1.69 | 1.83 | 1.98 | Upgrade
|
| Other Long-Term Liabilities | - | 1.67 | 2.11 | 1.85 | 0.4 | Upgrade
|
| Total Liabilities | 146.92 | 139.66 | 193.98 | 196.49 | 135.08 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 671.04 | 657.58 | 641.44 | 629.97 | 553.27 | Upgrade
|
| Retained Earnings | -161.65 | -308.58 | -506.26 | -478.02 | -412.11 | Upgrade
|
| Treasury Stock | -32.09 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 477.32 | 349.02 | 135.21 | 151.97 | 141.17 | Upgrade
|
| Total Liabilities & Equity | 624.24 | 488.68 | 329.18 | 348.46 | 276.25 | Upgrade
|
| Total Debt | 79.89 | 82.12 | 141.42 | 154.44 | 102.92 | Upgrade
|
| Net Cash (Debt) | 7.75 | 21.03 | -90.07 | -67.92 | -51.83 | Upgrade
|
| Net Cash Growth | -63.17% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.03 | 0.09 | -0.40 | -0.34 | -0.37 | Upgrade
|
| Filing Date Shares Outstanding | 238.16 | 237.62 | 228.22 | 222.16 | 195.92 | Upgrade
|
| Total Common Shares Outstanding | 237.87 | 236.62 | 226.06 | 221.82 | 195.81 | Upgrade
|
| Working Capital | 396.97 | 275.87 | 207.21 | 231.14 | 178.35 | Upgrade
|
| Book Value Per Share | 2.01 | 1.48 | 0.60 | 0.69 | 0.72 | Upgrade
|
| Tangible Book Value | 473.16 | 345.03 | 131.18 | 147.43 | 135.91 | Upgrade
|
| Tangible Book Value Per Share | 1.99 | 1.46 | 0.58 | 0.66 | 0.69 | Upgrade
|
| Land | 13.04 | 4.34 | 4.34 | 4.34 | 4.34 | Upgrade
|
| Buildings | 26.89 | 21.79 | 20.22 | 19.54 | 19.07 | Upgrade
|
| Machinery | 40.04 | 32.92 | 32.93 | 29.2 | 24.17 | Upgrade
|
| Construction In Progress | 8.46 | 8.15 | 2.27 | 6.73 | 5.5 | Upgrade
|
| Leasehold Improvements | 14.98 | 21.07 | 20.81 | 17.93 | 11.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.